Hot Products

Lappaol F
Catalog No: CFN95069

1. Lappaol F has antioxidant and antiaging properties, it may promote the C. elegans longevity and stress resistance through a JNK-1-DAF-16 cascade.
2. Lappaol F has potential chemosensitizing activity, it may be candidates for developing novel adjuvant anticancer agents.
3. Lappaol F exhibits antitumor activity in vitro and in vivo and has strong potential to be developed as an anticancer therapeutic.
4. Lappaol F strongly inhibited NO production in the LPS-stimulated RAW264.7 cells with the IC(50) value of 9.5 microM.

L-Arginine
Catalog No: CFN90550

L-Arginine is the nitrogen donor for synthesis of nitric oxide, a potent vasodilator that is deficient during times of sickle cell crisis. L-Arginine exhibits anti-atherosclerotic effect, L-arginine and soy enriched diet are effective in prevention of osteoporosis associated with diabetes mellitus. Exogenous L-Arginine could enhance neonate lymphocyte proliferation through an interleukin-2-independent pathway.

Lariciresinol
Catalog No: CFN98324

Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

Lariciresinol 4'-O-glucoside
Catalog No: CFN95400

Lariciresinol 4-O-glucoside
Catalog No: CFN95389

Lariciresinol acetate
Catalog No: CFN97679

Reference standards.

Laricitrin
Catalog No: CFN70400

Laricitrin is a novel flavonoid ABCG2 inhibitor, it suppresses certain factors and decreases the progression of lung cancer cells that are promoted by BaP in the lung cancer tumor microenvironment. Laricitrin could be an efficacious immunoadjuvant and have a synergistic effect when combined with chemotherapy.

Laricitrin 3-O-glucoside
Catalog No: CFN80175

Laricitrin 3-O-glucoside has antioxidant property.

Lasiocarpine
Catalog No: CFN00289

Lasiocarpine has antimitotic action,it has hepatocarcinogenicity, the effect can be better explained by its strong selection (promotion) influence on initiated hepatocytes, rather than by its very weak initiating activity.

Lasiocarpine N-oxide
Catalog No: CFN00290

Lasiocarpine-N-oxide shows antimicrobial activity against selected pathogenic bacteria and fungi.